Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

603
The pathophysiology of pneumonia involves the following steps:
603
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

345
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
345
Pneumonia IV: Management01:28

Pneumonia IV: Management

456
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
456

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Twenty-five years of human metapneumovirus research.

Clinical microbiology reviews·2026
Same author

Landscape of Prophylactic Strategies Against Human Parainfluenza Virus Type 3.

Reviews in medical virology·2025
Same author

Long COVID Symptom Management Through Self-Care and Nonprescription Treatment Options: A Narrative Review.

International journal of environmental research and public health·2025
Same author

Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor.

NPJ vaccines·2025
Same author

In Silico Analysis of Mechanisms of Maribavir-Induced Inhibition and Drug Resistance Mutations in pUL97 Kinase Structural Prediction with AlphaFold2.

Viruses·2025
Same author

Influenza A virus interferes with respiratory syncytial virus in mice and reconstituted human airway epithelium.

Microbiology spectrum·2025

相关实验视频

Updated: Sep 18, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.2K

对人类肺炎病毒的疫苗开发

Elhadji Birane Mboup1, Marie-Ève Hamelin1,2, Julia Dubois2,3,4

  • 1Infectious and Immune Diseases Research Program, CHU de Québec-Université Laval Research Center, Québec, QC G1V 4G2, Canada.

Vaccines
|June 27, 2025
PubMed
概括

目前已批准了三种呼吸道同胞病毒 (RSV) 疫苗,提供了新的预防方法. 然而,对于人类甲肺炎病毒 (HMPV) 的疫苗仍然是必要的,组合疫苗显示出未来的希望.

关键词:
临床试验临床试验临床试验临床试验临床试验人类甲型肺炎病毒 (HMPV)下呼吸道感染 (LRTI) 的病例肺炎病毒的感染呼吸道同胞性病毒 (RSV)疫苗 疫苗 疫苗 疫苗

更多相关视频

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.7K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K

相关实验视频

Last Updated: Sep 18, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.2K
Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.7K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K

科学领域:

  • 病毒学 病毒学
  • 免疫学 免疫学 免疫学
  • 疫苗学 疫苗学 疫苗学

背景情况:

  • 肺炎病毒,包括呼吸道同胞性病毒 (RSV) 和人类甲肺炎病毒 (HMPV),导致全球显著的呼吸道疾病和死亡率.
  • 幼儿,老年人和免疫力低下的人特别容易受到严重后果的影响.
  • 低收入和中等收入国家承担了不成比例的肺炎病毒相关死亡负担.

研究的目的:

  • 审查已批准的RSV疫苗的临床试验.
  • 检查RSV疫苗研究中的突出的平台技术.
  • 讨论针对RSV,HMPV和人类偏流感病毒3型 (HPIV3) 的组合疫苗.

主要方法:

  • 对已批准的RSV疫苗的临床试验数据的分析.
  • 审查新兴的RSV疫苗平台技术.
  • 在临床开发中讨论组合疫苗候选人.

主要成果:

  • 三种RSV疫苗 (AREXVY®,ABRYSVO®,mRESVIA®) 已获得批准,主要用于老年人.
  • 艾布里斯沃®通过母体疫苗接种为婴儿提供被动免疫.
  • RSV疫苗技术和组合疫苗正在积极临床评估中.

结论:

  • 在RSV疫苗开发方面取得了重大进展,有多种已批准的选择.
  • 对HMPV的疫苗仍然是一个关键的未满足的医疗需求.
  • 组合疫苗代表了一种有前途的战略,可以广泛保护人们免受多种呼吸道病毒的影响.